FREE Account Opening + No Clearing Fees
Loading...

Dipna Pharmachem Ltd. Rights Issue (Dipna Pharmachem Rights Issue 2024) Detail

February 26, 2024 - March 20, 2024
Dipna Pharmachem Ltd. Logo

Incorporated in 2011, Dipna Pharmachem Limited (DPL) is an India-based company that trades, imports, and exports industrial chemical and pharmaceutical raw materials.These include active pharmaceutical ingredients (APIs), excipients, and chemical formulation products.

The company exports its products globally. Dipna Pharmachem Limited offers import and export services to customers worldwide.

The company has a wide range of offerings, including expertise in marketing and sourcing of industrial chemicals, pharmaceutical raw materials, APIs, solvents, and formulation and intermediates. They also provide assistance in setting up contract manufacturing compliance for regulated and semi-regulated pharmaceutical companies, ensuring that all global benchmark parameters are met and leading certificates like WHO-GMP are obtained.

Dipna Pharmachem Rights Issue 2024 Detail

Issue Open February 26, 2024 - March 20, 2024
Security Name Dipna Pharmachem Ltd.
Issue Size (Shares) 12,967,500
Issue Size (Amount) ₹12.97 Crores
Issue Price ₹10 per share
Face Value ₹10 per share
Listing At BSE
Terms of Payment

Full amount of Rs. 10/- per Equity share is payable on application by Eligible Equity shareholders.

Entitlement 13 Rights Equity Share(s) for every 12 fully paid-up Equity Shares held on Record Date

Dipna Pharmachem Rights Issue 2024 Issue Timetable

Last Date to buy sharesFebruary 9, 2024
Record Date February 12, 2024
Credit of Rights Entitlements February 19, 2024
Bid/Offer Opens On February 26, 2024
Renunciation of Rights Entitlements March 4, 2024
Bid/Offer Closes On March 20, 2024
Deemed Date of Allotment March 14, 2024
Credit Date March 15, 2024
Listing Date March 18, 2024

Company Financials

Dipna Pharmachem Ltd. Financial Information (Restated)

Dipna Pharmachem Ltd.'s revenue increased by 37.34% and profit after tax (PAT) dropped by -21.85% between the financial year ending with March 31, 2023 and March 31, 2022.

Period Ended31 Mar 202331 Mar 2022
Assets77.5636.23
Revenue99.9372.77
Profit After Tax0.911.17
Reserves and Surplus12.391.70
Amount in ₹ Crore

Objects of the Issue:

The company intends to utilize the net proceeds from the issue towards the funding of the following objects:

  1. Incremental working capital requirements; and
  2. General Corporate Purpose.

Dipna Pharmachem Rights Issue 2024 Subscription Status

Dipna Pharmachem Rights Issue 2024 got oversubscribed by 1.03 times by the end of the bidding period with total bid quantity received by BSE of 13,351,000 shares.

Dipna Pharmachem Rights Issue 2024 Documents

Dipna Pharmachem Rights Issue 2024 Rating

9
3.6
Rating:Rated 3.6 stars
Vote Here ...

Dipna Pharmachem Rights Issue 2024 Reviews

Company Contact Information

Dipna Pharmachem Ltd.
A/211, Siddhi Vinayak Complex,
Near D.A.V. School
Makarba, Ahmedabad – 380 055

Phone: +91 98980 66121
Email: dharachem99@yahoo.in
Website: https://dipnapharmachem.com/

Dipna Pharmachem Rights Issue 2024 Registrar

  1. Bigshare Services Pvt Ltd
    Phone: +91-22-6263 8200
    Email: rightsissue@bigshareonline.com
    Website: https://ipo.bigshareonline.com/ipo_status.html

Dipna Pharmachem Rights Issue 2024 Lead Manager(s)

Dipna Pharmachem Rights Issue 2024 FAQs

The Dipna Pharmachem Rights Issue 2024 opens on February 26, 2024, and closes on March 20, 2024.

Dipna Pharmachem Rights Issue 2024 Schedule

Last Date for credit of Rights EntitlementsFebruary 19, 2024
Last Date for renunciation of Rights EntitlementsMarch 4, 2024
Issue Opening DateFebruary 26, 2024
Issue Closing DateMarch 20, 2024
Date of Allotment (on or about)March 14, 2024
Date of Credit (on or about)March 15, 2024
Date of Listing (on or about)March 18, 2024

Dipna Pharmachem Rights Issue 2024 price is set at ₹10 per share per equity share.

The eligible shareholders are being offered 13 Rights Equity Share(s) for every 12 fully paid-up Equity Shares held on Record Date (February 12, 2024).

The record date for the Dipna Pharmachem Rights Issue 2024 is February 12, 2024.

The issue size of Dipna Pharmachem Rights Issue 2024 is of 12,967,500 equity shares at ₹10 per share aggregating upto ₹12.97 Crores.

The Letter of Offer for Dipna Pharmachem Rights Issue 2024 can be download here.

You can apply for Dipna Pharmachem Rights Issue 2024 in two ways:

  1. Net Banking (ASBA)
  2. Registrar's Website (R-WAP Facility)

Steps to apply for Dipna Pharmachem Rights Issue 2024 using Net Banking (ASBA)

  1. Log in to the net banking account of your bank.
  2. Go to the 'IPO & Rights Issue' section.
  3. Check if the Dipna Pharmachem Rights Issue 2024 available on the list.
  4. Click the Apply button next to the Dipna Pharmachem Rights Issue 2024.
  5. Fill and check your information.
  6. Submit the application.

Note: Your bank may not offer this facility to certain rights issues. In that case, you may have to choose the option below.

Steps to apply for Dipna Pharmachem Rights Issue 2024 using Registrar's website (R-WAP)

  1. Visit registrar's website
  2. Go to the 'Rights Issue' section
  3. Select Dipna Pharmachem Rights Issue 2024 from the dropdown.
  4. Enter Demat Account Number.
  5. Fill the online application form.
  6. Validate and submit the application.

1 Comments

1. Murthy     Link|February 27, 2024 11:00:49 AM
Can we get the link for the full letter of offer where we can see all the details?
1.1. Murthy     Link|February 29, 2024 8:36:58 AM
https://www.bseindia.com/corporates/download/12794/Rights/DLOF_Revised_20231207144738.pdf

Compare rights issues with Dipna Pharmachem Rights Issue 2024